山高新能源(1250.HK)高開超4% 與控股股東共同打造“交通+新能源”發展新模式
格隆匯9月19日丨山高新能源(1250.HK)高開4.35%報0.048港元。消息面上,9月18日下午,公司發佈公吿稱,與間接控股股東山東高速集團訂立合作備忘錄,共同打造“交通+新能源”發展新模式,助力公司高速、高質發展。該集團指,將為控股股東的服務區、物流園區等提供綠色能源綜合解決方案,建設低碳或零碳服務區、園區及城市,獲支持建設輻射山東全省的綜合能源服務網絡,推動增量配網、區域配售電、綠證交易等業務;參與投資建設山東省風電光伏基地機遇、拓展海外新能源業,以及控股股東把新能源資產通過該集團作資產證券化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.